knowledge -WSS

knowledge

author：focus 2025-09-28 00:47:28 - browse：7228

A person walks past the Palantir sign. -- health tech coverage from STAT — FABRICE COFFRINI/AFP via Getty Images

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.

Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools.

For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： After Sarepta trial failure, Duchenne families brace for more debate

focus

WSS

Coloradans with cystic fibrosis could lose access to Trikafta

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

STAT Summit: How researchers deal with rejection

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Roche drug slashes death risk in early

Cassava Sciences’ Alzheimer’s clinical trials should be halted

knowledge

knowledge

hotspot

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Medical leaders decry Supreme Court decision on affirmative action

STAT Summit: Ending the crisis of Black deaths in the U.S.

Malaria cases in Florida and Texas: Here’s what you need to know

All of Us, NIH's precision medicine initiative, gets a big boost

Moonlake's readout produced a cash windfall. Risks remain

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

New air purifier tech could be key to improving indoor air quality

Kidney transplant patients stopped immunosuppressants in trial

explore

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Roche drug slashes death risk in early

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

CZI to create biohub to build anti

How AI can help patients find reliable information about doctors

focus

leisure time

focus

focus